sr141716 has been researched along with 1-(2,3-dichlorobenzoyl)-5-methoxy-2-methyl-(2-(mopholin-4-yl)ethyl)-1h-indole in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Angus, JA; Christopoulos, A; McRae, K; Moloney, GP; Robertson, AD; Robinson, M; Stoermer, MJ; Wright, CE | 1 |
Brogi, S; Corelli, F; Di Marzo, V; Ligresti, A; Mugnaini, C; Pasquini, S; Tafi, A | 1 |
Alauddin, MM; Gelovani, JG; Ivanov, RA; Rabinovich, B; Shavrin, A; Turkman, N; Volgin, A | 1 |
3 other study(ies) available for sr141716 and 1-(2,3-dichlorobenzoyl)-5-methoxy-2-methyl-(2-(mopholin-4-yl)ethyl)-1h-indole
Article | Year |
---|---|
Synthesis and cannabinoid activity of 1-substituted-indole-3-oxadiazole derivatives: novel agonists for the CB1 receptor.
Topics: Analgesics; Animals; Binding Sites; Cannabinoids; Drug Design; Hydrogen Bonding; Hydrophobic and Hydrophilic Interactions; Indoles; Inhibitory Concentration 50; Mice; Oxadiazoles; Rats; Receptor, Cannabinoid, CB1; Substrate Specificity | 2008 |
Three-dimensional quantitative structure-selectivity relationships analysis guided rational design of a highly selective ligand for the cannabinoid receptor 2.
Topics: Computer Simulation; Drug Design; Humans; Ligands; Models, Molecular; Molecular Structure; Quantitative Structure-Activity Relationship; Quinolones; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Recombinant Proteins; Stereoisomerism | 2011 |
Fluorinated cannabinoid CB2 receptor ligands: synthesis and in vitro binding characteristics of 2-oxoquinoline derivatives.
Topics: Binding, Competitive; Cell Line, Tumor; Dose-Response Relationship, Drug; Glioma; Humans; Ligands; Molecular Structure; Quinolones; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Stereoisomerism; Structure-Activity Relationship | 2011 |